WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997035997) RECOMBINANT POX VIRUS ENCODING MYELIN PROTEIN FOR THERAPY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/035997    International Application No.:    PCT/US1997/005217
Publication Date: 02.10.1997 International Filing Date: 25.03.1997
Chapter 2 Demand Filed:    30.09.1997    
IPC:
A61K 39/00 (2006.01), A61K 48/00 (2006.01), C07K 14/47 (2006.01), C12N 15/863 (2006.01)
Applicants: THERION BIOLOGICS CORPORATION [US/US]; 76 Rogers Street, Cambridge, MA 02142 (US) (For All Designated States Except US).
BETH ISRAEL DEACONNES MEDICAL CENTER [US/US]; 330 Brookline Avenue, Boston, MA 02215 (US) (For All Designated States Except US).
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA [US/US]; 22nd floor, 300 Lakeside Drive, Oakland, CA 94612-3550 (US) (For All Designated States Except US).
LETVIN, Norman [US/US]; (US) (For US Only).
GENAIN, Claude, P. [US/US]; (US) (For US Only).
GRITZ, Linda [US/US]; (US) (For US Only).
HAUSER, Stephen, H. [US/US]; (US) (For US Only).
PANICALI, Dennis [US/US]; (US) (For US Only)
Inventors: LETVIN, Norman; (US).
GENAIN, Claude, P.; (US).
GRITZ, Linda; (US).
HAUSER, Stephen, H.; (US).
PANICALI, Dennis; (US)
Agent: EISENSTEIN, Ronald, I.; Dike, Bronstein, Roberts & Cushman, L.L.P., 130 Water Street, Boston, MA 02109 (US)
Priority Data:
60/014,033 25.03.1996 US
Title (EN) RECOMBINANT POX VIRUS ENCODING MYELIN PROTEIN FOR THERAPY
(FR) POXVIRUS RECOMBINANT CODANT POUR LA PROTEINE DE LA MYELINE ET DESTINE A UN USAGE THERAPEUTIQUE
Abstract: front page image
(EN)A recombinant pox virus encoding a myelin protein is described. The recombinant pox virus can be used for generating an immune response to the myelin protein. This method involves introducing a sufficient amount of the pox virus to present the myelin protein to the immune system, expressing this myelin protein and presenting the myelin protein to the immune system.
(FR)L'invention concerne un poxvirus recombinant codant pour une protéine de la myéline, qui peut être utilisé pour provoquer des réponses immunitaires contre ladite protéine. La méthode comprend l'introduction d'une quantité suffisante de poxvirus pour présenter la protéine de myéline au système immunitaire, l'expression de ladite protéine et sa présentation au système immunitaire.
Designated States: AU, CA, JP, US.
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM).
Publication Language: English (EN)
Filing Language: English (EN)